Journey Strategic Wealth LLC Madrigal Pharmaceuticals, Inc. Transaction History
Journey Strategic Wealth LLC
- $3.03 Billion
- Q2 2025
A detailed history of Journey Strategic Wealth LLC transactions in Madrigal Pharmaceuticals, Inc. stock. As of the latest transaction made, Journey Strategic Wealth LLC holds 13,078 shares of MDGL stock, worth $4.7 Million. This represents 0.13% of its overall portfolio holdings.
Number of Shares
13,078
Previous 13,078
-0.0%
Holding current value
$4.7 Million
Previous $4.33 Million
8.64%
% of portfolio
0.13%
Previous 0.15%
Shares
9 transactions
Others Institutions Holding MDGL
# of Institutions
363Shares Held
23.4MCall Options Held
965KPut Options Held
419K-
Janus Henderson Group PLC London, X02.21MShares$792 Million0.42% of portfolio
-
John Paulson Paulson & Co. Inc. | New York, Ny2.1MShares$754 Million39.89% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.02MShares$726 Million10.84% of portfolio
-
Rtw Investments, LP New York, NY1.99MShares$716 Million10.82% of portfolio
-
Baker Bros. Advisors LP New York, NY1.97MShares$709 Million7.8% of portfolio
About MADRIGAL PHARMACEUTICALS, INC.
- Ticker MDGL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 17,103,400
- Market Cap $6.14B
- Description
- Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...